Centene Co. (NYSE:CNC) Shares Sold by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. trimmed its stake in shares of Centene Co. (NYSE:CNC) by 2.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 204,900 shares of the company’s stock after selling 5,000 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in Centene were worth $15,425,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of CNC. Park Place Capital Corp increased its stake in Centene by 1,190.0% during the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after buying an additional 357 shares in the last quarter. WR Wealth Planners LLC increased its position in shares of Centene by 41.4% during the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after purchasing an additional 137 shares in the last quarter. Chris Bulman Inc acquired a new position in Centene in the 2nd quarter valued at $33,000. Riverview Trust Co lifted its holdings in Centene by 154.6% in the 2nd quarter. Riverview Trust Co now owns 527 shares of the company’s stock valued at $35,000 after purchasing an additional 320 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new stake in shares of Centene in the second quarter valued at about $36,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Stock Up 0.5 %

CNC stock opened at $63.82 on Tuesday. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.17. The firm has a market cap of $32.22 billion, a PE ratio of 11.08, a P/E/G ratio of 0.85 and a beta of 0.49. Centene Co. has a 12 month low of $59.77 and a 12 month high of $81.42. The firm has a 50 day simple moving average of $70.97 and a 200 day simple moving average of $71.89.

Analyst Ratings Changes

Several research analysts have recently weighed in on CNC shares. Wells Fargo & Company lowered their target price on Centene from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Monday. Robert W. Baird lowered their price objective on Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a research note on Friday, October 25th. Deutsche Bank Aktiengesellschaft raised their target price on Centene from $82.00 to $87.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Stephens reissued an “equal weight” rating and issued a $78.00 price objective on shares of Centene in a report on Monday, August 5th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Centene from $85.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, July 10th. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $83.92.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.